Gordon Research Conference on Lipoprotein Metabolism

描述（由申请人提供）：本申请是为2002年6月16日至21日在新罕布什尔州梅里登的金博尔联合学院举行的2002年戈登脂蛋白代谢研究会议提供部分支持。会议的题目是“脂蛋白代谢的分子机制和调控”。本次国际会议将重点关注脂蛋白代谢的重要新发展，特别是那些影响人类代谢疾病和动脉粥样硬化性血管疾病发展的领域。将介绍基本的分子和细胞生物学研究以及人类和动物模型的体内研究。主题将包括高密度脂蛋白代谢、胆固醇转运、胰岛素抵抗、核受体和基因组学的应用。计划举行九次会议，内容包括：

DESCRIPTION (provided by applicant): This application is for partial support of the 2002 Gordon Research Conference on Lipoprotein Metabolism to be held at Kimball Union Academy in Meriden, New Hampshire on June 16-21, 2002. The title of the conference is "Molecular Mechanisms and Regulation of Lipoprotein Metabolism." This international conference will focus on important new developments in lipoprotein metabolism, particularly in those areas that impact on human metabolic disease and the development of atherosclerotic vascular disease. Basic molecular and cell biological studies and in vivo studies in humans and animal models will be presented. Topics will include high density lipoprotein metabolism, cholesterol transport, insulin resistance, nuclear receptors, and the application of genomics. Nine sessions are planned and will cover: 1. HDL Apolipoprotein Structure-Function 2. Genetics and In Vivo Regulation of HDL Metabolism and Reverse Cholesterol Transport 3. Niemann Pick C Disease and Intracellular Trafficking of Cholesterol 4. Reverse Cholesterol Transport 5. Insulin Resistance and Hyperlipidemia 6. Nuclear Receptors and Lipoprotein Metabolism 7. Lipid Metabolism in the Brain 8. Genomics and the Study of Lipid Metabolism 9. Keynote Speaker: H. Bryan Brewer This conference will be a major vehicle for the presentation and integration of the latest developments in lipoprotein and lipid metabolism. Emphasis will be placed on in-depth presentations and thorough discussions of new, largely unpublished studies. Important aims of the Gordon Research Conference on Lipoprotein Metabolism are to include the diversity of qualified professionals and to foster interactions among young investigators, post-doctoral fellows, graduate students, and senior investigators.